These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 30557739)

  • 1. Pruritus Is Common and Undertreated in Patients With Primary Biliary Cholangitis in the United Kingdom.
    Hegade VS; Mells GF; Fisher H; Kendrick S; DiBello J; Gilchrist K; Alexander GJ; Hirschfield GM; Sandford RN; Jones DEJ;
    Clin Gastroenterol Hepatol; 2019 Jun; 17(7):1379-1387.e3. PubMed ID: 30557739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of Risk Scoring Systems in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis.
    Efe C; Taşçilar K; Henriksson I; Lytvyak E; Alalkim F; Trivedi H; Eren F; Eliasson J; Beretta-Piccoli BT; Fischer J; Calişkan AR; Chayanupatkul M; Coppo C; Ytting H; Purnak T; Muratori L; Werner M; Muratori P; Rorsman F; Önnerhag K; Günşar F; Nilsson E; Heurgué-Berlot A; Güzelbulut F; Demir N; Gönen C; Semela D; Aladağ M; Kiyici M; Schiano TD; Montano-Loza AJ; Berg T; Ozaslan E; Yoshida EM; Bonder A; Marschall HU; Wahlin S
    Am J Gastroenterol; 2019 Jul; 114(7):1101-1108. PubMed ID: 31241547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Bezafibrate on Outcome and Pruritus in Primary Biliary Cholangitis With Suboptimal Ursodeoxycholic Acid Response.
    Reig A; Sesé P; Parés A
    Am J Gastroenterol; 2018 Jan; 113(1):49-55. PubMed ID: 29016567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obeticholic acid for the treatment of primary biliary cholangitis.
    Ali AH; Lindor KD
    Expert Opin Pharmacother; 2016 Sep; 17(13):1809-15. PubMed ID: 27468093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of Pruritus in Primary Biliary Cholangitis: A Narrative Review.
    Trivedi HD; Lizaola B; Tapper EB; Bonder A
    Am J Med; 2017 Jun; 130(6):744.e1-744.e7. PubMed ID: 28238692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors Associated With Prevalence and Treatment of Primary Biliary Cholangitis in United States Health Systems.
    Lu M; Li J; Haller IV; Romanelli RJ; VanWormer JJ; Rodriguez CV; Raebel MA; Boscarino JA; Schmidt MA; Daida YG; Sahota A; Vincent J; Bowlus CL; Lindor K; Rupp LB; Gordon SC;
    Clin Gastroenterol Hepatol; 2018 Aug; 16(8):1333-1341.e6. PubMed ID: 29066370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BAT117213: Ileal bile acid transporter (IBAT) inhibition as a treatment for pruritus in primary biliary cirrhosis: study protocol for a randomised controlled trial.
    Hegade VS; Kendrick SF; Dobbins RL; Miller SR; Richards D; Storey J; Dukes G; Gilchrist K; Vallow S; Alexander GJ; Corrigan M; Hirschfield GM; Jones DE
    BMC Gastroenterol; 2016 Jul; 16(1):71. PubMed ID: 27431238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pruritus in patients with chronic liver disease and serum autotaxin levels in patients with primary biliary cholangitis.
    Fujino H; Tanaka M; Imamura M; Morio K; Ono A; Nakahara T; Murakami E; Kawaoka T; Takahashi S; Miki D; Tsuge M; Hiramatsu A; Aikata H; Hayes CN; Chayama K
    BMC Gastroenterol; 2019 Oct; 19(1):169. PubMed ID: 31651244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Geoepidemiology of Primary Biliary Cholangitis: Lessons from Switzerland.
    Terziroli Beretta-Piccoli B; Stirnimann G; Cerny A; Semela D; Hessler R; Helbling B; Stickel F; Kalid-de Bakker C; Bihl F; Giostra E; Filipowicz Sinnreich M; Oneta C; Baserga A; Invernizzi P; Carbone M; Mertens J
    Clin Rev Allergy Immunol; 2018 Apr; 54(2):295-306. PubMed ID: 29181702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rate of non-response to ursodeoxycholic acid in a large real-world cohort of primary biliary cholangitis patients in Italy.
    Vespasiani-Gentilucci U; Rosina F; Pace-Palitti V; Sacco R; Pellicelli A; Chessa L; De Vincentis A; Barlattani M; Barlattani A; Feletti V; Mussetto A; Zolfino T; Russello M; Cozzolongo R; Garrucciu G; Niro G; Bacca D; Bertino G; Claar E; Ascione A; D'Adamo G; Adinolfi LE; Scifo G; Izzi A;
    Scand J Gastroenterol; 2019 Oct; 54(10):1274-1282. PubMed ID: 31564176
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of ileal bile acid transporter inhibitor GSK2330672 on pruritus in primary biliary cholangitis: a double-blind, randomised, placebo-controlled, crossover, phase 2a study.
    Hegade VS; Kendrick SF; Dobbins RL; Miller SR; Thompson D; Richards D; Storey J; Dukes GE; Corrigan M; Oude Elferink RP; Beuers U; Hirschfield GM; Jones DE
    Lancet; 2017 Mar; 389(10074):1114-1123. PubMed ID: 28187915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors Associated With Progression and Outcomes of Early Stage Primary Biliary Cholangitis.
    Gatselis NK; Goet JC; Zachou K; Lammers WJ; Janssen HLA; Hirschfield G; Corpechot C; Lindor KD; Invernizzi P; Mayo MJ; Battezzati PM; Floreani A; Pares A; Lygoura V; Nevens F; Mason AL; Kowdley KV; Ponsioen CY; Bruns T; Thorburn D; Verhelst X; Harms MH; van Buuren HR; Hansen BE; Dalekos GN;
    Clin Gastroenterol Hepatol; 2020 Mar; 18(3):684-692.e6. PubMed ID: 31419573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Age and Sex of Response to Ursodeoxycholic Acid and Transplant-free Survival in Patients With Primary Biliary Cholangitis.
    Cheung AC; Lammers WJ; Murillo Perez CF; van Buuren HR; Gulamhusein A; Trivedi PJ; Lazaridis KN; Ponsioen CY; Floreani A; Hirschfield GM; Corpechot C; Mayo MJ; Invernizzi P; Battezzati PM; Parés A; Nevens F; Thorburn D; Mason AL; Carbone M; Kowdley KV; Bruns T; Dalekos GN; Gatselis NK; Verhelst X; Lindor KD; Lleo A; Poupon R; Janssen HLA; Hansen BE;
    Clin Gastroenterol Hepatol; 2019 Sep; 17(10):2076-2084.e2. PubMed ID: 30616022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptom Burden and Treatment Response in Patients with Primary Biliary Cholangitis (PBC).
    Kaps L; Grambihler A; Yemane B; Nagel M; Labenz C; Ploch P; Michel M; Galle PR; Wörns MA; Schattenberg JM
    Dig Dis Sci; 2020 Oct; 65(10):3006-3013. PubMed ID: 31853781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The UK-PBC risk scores: Derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis.
    Carbone M; Sharp SJ; Flack S; Paximadas D; Spiess K; Adgey C; Griffiths L; Lim R; Trembling P; Williamson K; Wareham NJ; Aldersley M; Bathgate A; Burroughs AK; Heneghan MA; Neuberger JM; Thorburn D; Hirschfield GM; Cordell HJ; Alexander GJ; Jones DE; Sandford RN; Mells GF;
    Hepatology; 2016 Mar; 63(3):930-50. PubMed ID: 26223498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrates for Itch (FITCH) in Fibrosing Cholangiopathies: A Double-Blind, Randomized, Placebo-Controlled Trial.
    de Vries E; Bolier R; Goet J; Parés A; Verbeek J; de Vree M; Drenth J; van Erpecum K; van Nieuwkerk K; van der Heide F; Mostafavi N; Helder J; Ponsioen C; Oude Elferink R; van Buuren H; Beuers U;
    Gastroenterology; 2021 Feb; 160(3):734-743.e6. PubMed ID: 33031833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of fenofibrate add-on therapy for patients with primary biliary cholangitis and a suboptimal response to UDCA.
    Duan W; Ou X; Wang X; Wang Y; Zhao X; Wang Q; Wu X; Zhang W; Ma H; You H; Jia J
    Rev Esp Enferm Dig; 2018 Sep; 110(9):557-563. PubMed ID: 29739227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pruritus in primary biliary cholangitis is under-recorded in patient medical records.
    Gungabissoon U; Smith HT; von Maltzahn R; Logie J; Fairburn-Beech J; Ma L; P D; McGirr A; Hunnicutt JN; Rowe CL; Tierney M; Friedler HS
    BMJ Open Gastroenterol; 2024 Mar; 11(1):. PubMed ID: 38538090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy.
    Tang R; Wei Y; Li Y; Chen W; Chen H; Wang Q; Yang F; Miao Q; Xiao X; Zhang H; Lian M; Jiang X; Zhang J; Cao Q; Fan Z; Wu M; Qiu D; Fang JY; Ansari A; Gershwin ME; Ma X
    Gut; 2018 Mar; 67(3):534-541. PubMed ID: 28213609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of S-adenosyl-L-methionine on liver biochemistry and quality of life in patients with primary biliary cholangitis treated with ursodeoxycholic acid. A prospective, open label pilot study.
    Wunsch E; Raszeja-Wyszomirska J; Barbier O; Milkiewicz M; Krawczyk M; Milkiewicz P
    J Gastrointestin Liver Dis; 2018 Sep; 27(3):273-279. PubMed ID: 30240471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.